NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Kemin Industries, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

DED Partners with Kemin Industries to Announce $14 Million Expansion of Verona Facility - Expected creation of 24 new jobs - Kemin.com
DED Partners with Kemin Industries to Announce $14 Million Expansion of Verona Facility

 

NewswireTODAY - /newswire/ - Verona, MO, United States, 2014/04/18 - Expected creation of 24 new jobs - Kemin.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Missouri Department of Economic Development (DED) and Kemin Industries today announced that Kemin will expand its production facility in Verona, Mo. The 5-year expansion plan includes a more than $14 million capital investment and is expected to create 24 new jobs. The expansion will allow increased production capacity of the existing facility that manufactures meat protein used in palatants for premium and super premium pet foods.

“Kemin’s announcement today is another big win for Missouri,” said Mike Downing, Acting Director of the Missouri Department of Economic Development. “The company’s investment in our state will create good jobs and boost our economy. We’re proud to partner with Kemin on its expansion.”

This expansion will ensure Kemin is positioned to meet increased consumer demand for pet food. Kemin has been expanding its global palatant manufacturing capacity over the past several years, opening a new state-of-the-art facility in Veronella, Italy, and in 2008, acquiring a controlling interest in a manufacturing facility in Brazil. In 2011, Kemin purchased spray drying technology and a manufacturing facility in Verona from American Dehydrated Foods. With continued success, the company will expand its Verona plant, over the next 5-years, by approximately 40,000 square-feet to accommodate increased production capacity and warehouse space for future growth.

“Missouri’s prime location in the middle of the animal health science corridor has provided an excellent environment for our palatant plant,” said Giuseppe Abrate, president of Kemin Industries’ pet food ingredient division. “Access to diverse industry resources has served our business well and will help us achieve our vision of touching half the people, and pets, of the world with our products and services.”

“We are pleased that Kemin has decided to expand inside our city and can benefit from the Enhanced Enterprise Zone that we are a part of,” said Verona Mayor Willis Huston. “We hope that others will take advantage of it as we seek to revitalize the city.”

The Verona expansion is part of the company’s global expansion plan. Kemin is in the midst of a $40 million expansion at its corporate headquarters in Des Moines, Iowa, where it recently opened a new state-of-the-art research and development facility. When this expansion is complete, Kemin will have added six new manufacturing facilities, three research facilities and a new corporate headquarters building in Southeast Des Moines.

To assist Kemin with its expansion in Verona, the Department of Economic Development has authorized a strategic economic incentive package, estimated at over $300,000, which the company plans to receive by meeting the department’s strict job creation and investment criteria.

Kemin Inspired Molecular Solutions™

Kemin (kemin.com) provides “inspired molecular solutions” specifically developed to provide nutrition and health benefits for humans and animals. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where approximately 500 specialty ingredients are made for the global feed and food industries as well as the health, nutrition and beauty markets. A privately held, family-owned and operated company, Kemin has nearly 2,000 employees and operates in more than 90 countries with manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United States.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


DED Partners with Kemin Industries to Announce $14 Million Expansion of Verona Facility

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Tina Kendall - Kemin.com 
515-559-5562 tina.kendall[.]kemin.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kemin Industries, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 in Multiple System Atrophy At the 7th World Parkinson Con
Ipsen Announces Late-breaking Data from First Head-to-head Study Comparing Dysport® and Botox® in Adults with Upper Limb Spasticity
Ipsen Unveils Corabotase, A First-in-class Recombinant Neuroinhibitor, RNI™ At the SCALE Symposium
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure
Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition
Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment
Ono Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory
SCHOTT Pharma Launches EVERIC® Lyo & Amber Vials for Light-sensitive ADCs
Arbitration Tribunal Upholds Ipsen’s Termination of R&D Agreement with Galderma
New Data Reinforces Ipsen’s Commitment to Bringing Solutions and Addressing Care Gaps in Neurological Diseases At TOXINS
Opdivo® Intravenous Infusion Approved in Taiwan in Combination with Yervoy® for the Treatment of Adult Patients

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  JobsWare.com





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)